Skip to main content

CLINICAL TRIAL article

Front. Nutr.
Sec. Nutrition and Metabolism
Volume 11 - 2024 | doi: 10.3389/fnut.2024.1510318
This article is part of the Research Topic Dietary Patterns and Oxidative Stress: Implications for Obesity, T2D, and Cancer Management View all 3 articles

Effect of synbiotic supplementation on obesity and gut microbiota in obese adults: a double-blind randomized controlled trial

Provisionally accepted
晓康 牛 晓康 牛 1Qi Zhang Qi Zhang 1*Julong Liu Julong Liu 2*Yuyang Zhao Yuyang Zhao 1*Nan Shang Nan Shang 1Shusen Li Shusen Li 2*Yinghua Liu Yinghua Liu 3Wei Xiong Wei Xiong 4Erna Sun Erna Sun 2*Yong Zhang Yong Zhang 3Hongfeng Zhao Hongfeng Zhao 2*Yixuan Li Yixuan Li 1Pengjie Wang Pengjie Wang 1Bing Fang Bing Fang 1Liang Zhao Liang Zhao 1Juan Chen Juan Chen 1*Fuqing Wang Fuqing Wang 5*Guofang Pang Guofang Pang 6*Chenyuan Wang Chenyuan Wang 2*Jingjing He Jingjing He 1*Ran Wang Ran Wang 1*
  • 1 China Agricultural University, Beijing, China
  • 2 Mengniu Hi-Tech Dairy Product Beijing Co., Ltd, Beijing, China
  • 3 Department of Nutrition, The First Medical Center of Chinese PLA General Hospital, Beijing, China
  • 4 Food Laboratory of Zhongyuan, Luohe, China
  • 5 Tibet Tianhong Science and Technology Co., Ltd, Lhasa, China
  • 6 Chinese Academy of Inspection and Quarantine (CAIQ), Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

    Background: Synbiotics, combining specific probiotics and selected prebiotics, may benefit health issues like obesity, but evidence remains inconsistent. Objective: This study aimed to verify the effect of a pre-screened synbiotics combination (containing Bifidobacterium animalis subsp. lactis MN-Gup (MN-Gup), galacto-oligosaccharides (GOS) and xylo-oligosaccharides (XOS)) on obesity in the population. Methods: In a randomized, double-blind, placebocontrolled trial, 80 individuals with obesity consumed daily synbiotics (containing MN-Gup 1 × 10 11 CFU/day, GOS 0.7g/day, and XOS 0.7g/day) or placebo for 12 weeks. Body composition, blood lipids, serum hormone, bile acids, and gut microbiota were measured preand post-intervention. Results: Synbiotics supplementation significantly decreased body fat percentage, waist, and serum low-density lipoprotein cholesterol (LDL-C), increased peptide YY, cholecystokinin, oxyntomodulin, GSH (glutathione peroxidase) in individuals with obesity. Additionally, synbiotic supplementation led to an enrichment of beneficial bacteria and bile acids (Chenodeoxycholic Acid (CDCA). Bifidobacterium and Romboutsia were significantly positively correlated with CDCA. A more favorable effect was observed in individuals with obesity and abnormal LDL-C compared to those without dyslipidemia. Conclusion: 12-week synbiotics intervention reduced body fat percentage, waist, and serum LDL-C, especially in individuals with obesity and abnormal LDL-C. The possible mechanisms may be related to changes in gut microbiota, bile acids and gut hormones. The study was registered at Chictr.org.cn with a registration number of ChiCTR2200064156.

    Keywords: Bifidobacterium animalis subsp. lactis MN-Gup, Synbiotics, Obesity, Gut Microbiota, randomized controlled trial

    Received: 12 Oct 2024; Accepted: 15 Nov 2024.

    Copyright: © 2024 牛, Zhang, Liu, Zhao, Shang, Li, Liu, Xiong, Sun, Zhang, Zhao, Li, Wang, Fang, Zhao, Chen, Wang, Pang, Wang, He and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Qi Zhang, China Agricultural University, Beijing, China
    Julong Liu, Mengniu Hi-Tech Dairy Product Beijing Co., Ltd, Beijing, China
    Yuyang Zhao, China Agricultural University, Beijing, China
    Shusen Li, Mengniu Hi-Tech Dairy Product Beijing Co., Ltd, Beijing, China
    Erna Sun, Mengniu Hi-Tech Dairy Product Beijing Co., Ltd, Beijing, China
    Hongfeng Zhao, Mengniu Hi-Tech Dairy Product Beijing Co., Ltd, Beijing, China
    Juan Chen, China Agricultural University, Beijing, China
    Fuqing Wang, Tibet Tianhong Science and Technology Co., Ltd, Lhasa, China
    Guofang Pang, Chinese Academy of Inspection and Quarantine (CAIQ), Beijing, Beijing Municipality, China
    Chenyuan Wang, Mengniu Hi-Tech Dairy Product Beijing Co., Ltd, Beijing, China
    Jingjing He, China Agricultural University, Beijing, China
    Ran Wang, China Agricultural University, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.